Canada Life’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $237K | Buy |
28,262
+8,411
| +42% | +$88.4K | ﹤0.01% | 1582 |
|
|
2025
Q4 | $286K | Buy |
19,851
+5,341
| +37% | +$66.6K | ﹤0.01% | 1581 |
|
|
2025
Q3 | $143K | Buy |
14,510
+3,671
| +34% | +$32.5K | ﹤0.01% | 1724 |
|
|
2025
Q2 | $89K | Buy |
10,839
+7,924
| +272% | +$66.3K | ﹤0.01% | 1775 |
|
|
2025
Q1 | $21K | Sell |
2,915
-3,734
| -56% | -$27.8K | ﹤0.01% | 1933 |
|
|
2024
Q4 | $51K | Sell |
6,649
-36,699
| -85% | -$345K | ﹤0.01% | 1891 |
|
|
2024
Q3 | $454K | Sell |
43,348
-1,044
| -2% | -$12.7K | ﹤0.01% | 1694 |
|
|
2024
Q2 | $519K | Buy |
44,392
+7,181
| +19% | +$112K | ﹤0.01% | 1672 |
|
|
2024
Q1 | $783K | Buy |
37,211
+4,076
| +12% | +$72.5K | ﹤0.01% | 1560 |
|
|
2023
Q4 | $593K | Sell |
33,135
-20,514
| -38% | -$361K | ﹤0.01% | 1661 |
|
|
2023
Q3 | $883K | Buy |
53,649
+6,532
| +14% | +$118K | ﹤0.01% | 1529 |
|
|
2023
Q2 | $942K | Sell |
47,117
-4,385
| -9% | -$84.5K | ﹤0.01% | 1512 |
|
|
2023
Q1 | $974K | Sell |
51,502
-2,549
| -5% | -$56.4K | ﹤0.01% | 1515 |
|
|
2022
Q4 | $1.23M | Buy |
54,051
+3,945
| +8% | +$89.2K | ﹤0.01% | 1446 |
|
|
2022
Q3 | $1.32M | Buy |
50,106
+13,302
| +36% | +$395K | ﹤0.01% | 1370 |
|
|
2022
Q2 | $909K | Buy |
36,804
+4,818
| +15% | +$120K | ﹤0.01% | 1498 |
|
|
2022
Q1 | $1.09M | Sell |
31,986
-550
| -2% | -$15.3K | ﹤0.01% | 1497 |
|
|
2021
Q4 | $1.06M | Buy |
32,536
+272
| +0.8% | +$9.26K | ﹤0.01% | 1502 |
|
|
2021
Q3 | $1.36M | Buy |
32,264
+1,950
| +6% | +$70.2K | ﹤0.01% | 1386 |
|
|
2021
Q2 | $1.18M | Sell |
30,314
-58
| -0.2% | -$2.07K | ﹤0.01% | 1443 |
|
|
2021
Q1 | $1.03M | Buy |
30,372
+929
| +3% | +$39.6K | ﹤0.01% | 1499 |
|
|
2020
Q4 | $1.33M | Sell |
29,443
-3,869
| -12% | -$135K | ﹤0.01% | 1361 |
|
|
2020
Q3 | $917K | Sell |
33,312
-5,281
| -14% | -$172K | ﹤0.01% | 1444 |
|
|
2020
Q2 | $1.42M | Sell |
38,593
-1,459
| -4% | -$54.4K | ﹤0.01% | 1245 |
|
|
2020
Q1 | $1.29M | Buy |
40,052
+2,394
| +6% | +$99.7K | ﹤0.01% | 1166 |
|
|
2019
Q4 | $1.53M | Buy |
+37,658
| New | +$1.49M | ﹤0.01% | 1285 |
|
|
2019
Q3 | – | Sell |
-40,117
| Closed | -$2.06M | – | 2021 |
|
|
2019
Q2 | $2.06M | Sell |
40,117
-1,497
| -4% | -$74.7K | ﹤0.01% | 1166 |
|
|
2019
Q1 | $2.38M | Buy |
41,614
+2,865
| +7% | +$142K | 0.01% | 949 |
|
|
2018
Q4 | $1.5M | Buy |
38,749
+1,420
| +4% | +$83.3K | ﹤0.01% | 1192 |
|
|
2018
Q3 | $2.81M | Buy |
37,329
+1,679
| +5% | +$121K | 0.01% | 942 |
|
|
2018
Q2 | $2.56M | Buy |
35,650
+33,450
| +1,520% | +$1.6M | 0.01% | 1005 |
|
|
2018
Q1 | $66K | Hold |
2,200
| – | – | ﹤0.01% | 2295 |
|
|
2017
Q4 | $73K | Hold |
2,200
| – | – | ﹤0.01% | 2264 |
|
|
2017
Q3 | $70K | Hold |
2,200
| – | – | ﹤0.01% | 2248 |
|
|
2017
Q2 | $43K | Hold |
2,200
| – | – | ﹤0.01% | 2368 |
|
|
2017
Q1 | $42K | Hold |
2,200
| – | – | ﹤0.01% | 2346 |
|
|
2016
Q4 | $41K | Buy |
+2,200
| New | +$42K | ﹤0.01% | 2372 |
|
Other funds holding RGNX
RG
VCM
IHAM
Canada Life's RGNX Position: Q1 2026 in Review
Canada Life increased its Regenxbio (RGNX) stake by 42% in Q1 2026, buying an estimated $88.4K and bringing the position to 28,262 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.
Canada Life first reported a position in RGNX in Q4 2016 and has held it in 37 quarters since. The position peaked at $2.81M in Q3 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Canada Life held 28,262 shares of Regenxbio worth $237K as of Q1 2026.
- Canada Life bought 8,411 Regenxbio shares in Q1 2026, an estimated $88.4K.
- Regenxbio made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1582 holding.
- Canada Life first reported a position in Regenxbio in Q4 2016 and has held it in 37 quarters since.
- Canada Life's Regenxbio position peaked at $2.81M in Q3 2018.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.